GM1 ganglioside and Alzheimer's disease

Glycoconjugate Journal

Volumn 32, Issue 3-4, 2015, Pages 87-91

  Yanagisawa, Katsuhiko ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Conformational transition; Ganglioside; GM1 ganglioside bound A (GA ); Seed

Indexed keywords

AMYLOID BETA PROTEIN; GANGLIOSIDE GM1;

ALPHA HELIX; ALZHEIMER DISEASE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CONFORMATIONAL TRANSITION; DIMERIZATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN INTERACTION; REVIEW; RISK FACTOR; ANIMAL; BRAIN; CELL MEMBRANE; CEREBROSPINAL FLUID; CHEMISTRY; METABOLISM;

ANIMALIA;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CELL MEMBRANE; G(M1) GANGLIOSIDE; HUMANS;

EID: 84929955466     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-015-9579-5     Document Type: Review

References (34)

1. Yanagisawa, K., Odaka, A., Suzuki, N., Ihara, Y.: GM1 ganglioside-bound amyloid ß-protein (Aß): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1, 1062-1066 (1995)
2. Hayashi, H., Kimura, N., Yamaguchi, H., Hasegawa, K., Yokoseki, T., Shibata, M., Yamamoto, N., Michikawa, M., Yoshikawa, Y., Terao, K., Matsuzaki, K., Lemere, C.A., Selkoe, D.J., Naiki, H., Yanagisawa, K.: A seed for Alzheimer amyloid in the brain. J. Neurosci. 24(20), 4894-4902 (2004). doi: 10.1523/JNEUROSCI. 0861-04.2004
3. Yanagisawa, K.: Role of gangliosides in Alzheimer's disease. Biochim. Biophys. Acta 1768(8), 1943-1951 (2007)
4. Ariga, T., McDonald, M.P., Yu, R.K.: Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease- a review. J. Lipid Res. 49(6), 1157-1175 (2008). doi: 10.1194/jlr. R800007-JLR200
5. Matsuzaki, K., Kato, K., Yanagisawa, K.: Aβ polymerization through interaction with membrane gangliosides. Biochim. Biophys. Acta 1801(8), 868-877 (2010). doi: 10.1016/j.bbalip.2010.01.008
6. Knight, E.M., Williams, H.N., Stevens, A.C., Kim, S.H., Kottwitz, J.C., Morant, A.D., Steele, J.W., Klein, W.L., Yanagisawa, K., Boyd, R.E., Lockhart, D.J., Sjoberg, E.R., Ehrlich, M.E., Wustman, B.A., Gandy, S.: Evidence that small molecule enhancement of β-hexosaminidase activity corrects the behavioral phenotype in Dutch APP(E693Q) mice through reduction of ganglioside-bound Aβ. Mol. Psychiatry (2014). doi: 10.1038/mp.2014.135
7. Hong, S., Ostaszewski, B.L., Yang, T., O'Malley, T.T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., Selkoe, D.J.: Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes. Neuron 82(2), 308-319 (2014). doi: 10.1016/j.neuron.2014.02.027
8. Okabayashi, S., Shimozawa, N., Yasutomi, Y., Yanagisawa, K., Kimura, N.: Diabetes mellitus accelerates Aß pathology in brain accompanied by enhanced GAß generation in non-human primates. PLoS One (2015)
9. McLaurin, J., Franklin, T., Fraser, P.E., Chakrabartty, A.: Structural transitions associated with the interaction of Alzheimer β-amyloid peptides with gangliosides. J. Biol. Chem. 273(8), 4506-4515 (1998)
10. Kakio, A., Nishimoto, S., Yanagisawa, K., Kozutsumi, Y., Matsuzaki, K.: Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry 41(23), 7385-7390 (2002). doi: 10.1074/jbc.M100252200
11. Williamson, M.P., Suzuki, Y., Bourne, N.T., Asakura, T.: Binding of amyloid β-peptide to ganglioside micelles is dependent on histidine-13. Biochem. J. 397(3), 483-490 (2006). doi: 10.1042/BJ20060293
12. Fezoui, Y., Teplow, D.B.: Kinetic studies of amyloid β-protein fibril assembly. Differential effects of alpha-helix stabilization. J. Biol. Chem. 277(40), 36948-36954 (2002). doi: 10.1074/jbc.M204168200
13. Utsumi, M., Yamaguchi, Y., Sasakawa, H., Yamamoto, N., Yanagisawa, K., Kato, K.: Up-and-down topological mode of amyloid β-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters. Glycoconj. J. 26(8), 999-1006 (2009). doi: 10.1007/s10719-008-9216-7
14. Yagi-Utsumi, M., Kameda, T., Yamaguchi, Y., Kato, K.: NMR characterization of the interactions between lyso-GM1 aqueous micelles and amyloid β. FEBS Lett. 584(4), 831-836 (2010). doi: 10.1016/j.febslet.2010.01.005
15. Ikeda, K., Yamaguchi, T., Fukunaga, S., Hoshino, M., Matsuzaki, K.: Mechanism of amyloid β-protein aggregation mediated by GM1 ganglioside clusters. Biochemistry 50(29), 6433-6440 (2011). doi: 10.1021/bi200771m
16. Hoshino, T., Mahmood, M.I., Mori, K., Matsuzaki, K.: Binding and aggregation mechanism of amyloid β-peptides onto the GM1 ganglioside-containing lipid membrane. J. Phys. Chem. B 117(27), 8085-8094 (2013). doi: 10.1021/jp4029062
17. Yagi-Utsumi, M., Matsuo, K., Yanagisawa, K., Gekko, K., Kato, K.: Spectroscopic characterization of intermolecular interaction of amyloid β promoted on GM1 micelles. Int. J. Alzheimers Dis. 2011, 925073 (2010). doi: 10.4061/2011/925073
18. Manna, M., Mukhopadhyay, C.: Binding, conformational transition and dimerization of amyloid-β peptide on GM1-containing ternary membrane: insights from molecular dynamics simulation. PLoS ONE 8(8), e71308 (2013). doi: 10.1371/journal.pone.0071308
19. Kakio, A., Nishimoto, S.I., Yanagisawa, K., Kozutsumi, Y., Matsuzaki, K.: Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J. Biol. Chem. 276(27), 24985-24990 (2001)
20. Yuyama, K., Yanagisawa, K.: Sphingomyelin accumulation provides a favorable milieu for GM1 ganglioside-induced assembly of amyloid ß-protein. Neurosci. Lett. 481(3), 168-172 (2010). doi: 10.1016/j.neulet.2010.06.080
21. Mori, K., Mahmood, M.I., Neya, S., Matsuzaki, K., Hoshino, T.: Formation of GM1 ganglioside clusters on the lipid membrane containing sphingomyeline and cholesterol. J. Phys. Chem. B 116(17), 5111-5121 (2012). doi: 10.1021/jp207881k
22. Fantini, J., Yahi, N., Garmy, N.: Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation. Front. Physiol. 4, 120 (2013). doi: 10.3389/fphys.2013.00120
23. Matsubara, T., Iijima, K., Yamamoto, N., Yanagisawa, K., Sato, T.: Density of GM1 in nanoclusters is a critical factor in the formation of a spherical assembly of amyloid β-protein on synaptic plasma membranes. Langmuir 29(7), 2258-2264 (2013). doi: 10.1021/la3038999
24. Oikawa, N., Hatsuta, H., Murayama, S., Suzuki, A., Yanagisawa, K.: Influence of APOE genotype and the presence of Alzheimer's pathology on synaptic membrane lipids of human brains. J. Neurosci. Res. 92(5), 641-650 (2014). doi: 10.1002/jnr.23341
25. Cataldo, A.M., Peterhoff, C.M., Troncoso, J.C., Gomez-Isla, T., Hyman, B.T., Nixon, R.A.: Endocytic pathway abnormalites precede amyloid ß deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157(1), 277-286 (2000)
26. Yuyama, K., Yamamoto, N., Yanagisawa, K.: Chloroquine-induced endocytic pathway abnormalities: cellular model of GM1 ganglioside-induced Aß fibrillogenesis in Alzheimer's disease. FEBS Lett. 580(30), 6972-6976 (2006)
27. Yuyama, K., Yanagisawa, K.: Late endocytic dysfuntion as a putative cause of amyloid fibril formation in Alzheimer's disease. J. Neurochem. 109(5), 1250-1260 (2009). doi: 10.1111/j.1471-4159.2009.06046.x
28. Keilani, S., Lun, Y., Stevens, A.C., Williams, H.N., Sjoberg, E.R., Khanna, R., Valenzano, K.J., Checler, F., Buxbaum, J.D., Yanagisawa, K., Lockhart, D.J.: Wustman BA, Gandy S.: Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide. J. Neurosci. 32(15), 5223-5236 (2012). doi: 10.1523/JNEUROSCI. 4860-11.2012
29. Oikawa, N., Matsubara, T., Fukuda, T., Yasumori, H., Hatsuta H., Murayama, S., Sato, T., Suzuki, A., Yanagisawa, K.: Imbalance in fatty-acid-chain length of gangliosides triggers Alzheimer amyloid deposition. PLoS One (2015)
30. Jarrett, J.T., Lansbury, P.T.: Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 31(49), 12345-12352 (1992)
31. Jarrett, J.T., Lansbury, P.T.: Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73(6), 1055-1058 (1993)
32. Esler, W.P., Stimson, E.R., Jennings, J.M., Vinters, H.V., Ghilardi, J.R., Lee, J.P., Mantyh, P.W., Maggio, J.E.: Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39(21), 6288-6295 (2000)
33. Okada, T., Ikeda, K., Wakabayashi, M., Ogawa, M., Matsuzaki, K.: Formation of toxic Aβ(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Aβ(1-40) fibrils. J. Mol. Biol. 382(4), 1066-1074 (2008). doi: 10.1016/j.jmb.2008.07.072
34. Fukunaga, S., Ueno, H., Yamaguchi, T., Yano, Y., Hoshino, M., Matsuzaki, K.: GM1 cluster mediates formation of toxic Aβ fibrils by providing hydrophobic environments. Biochemistry 51(41), 8125-8131 (2012). doi: 10.1021/bi300839u